CHR Metz-Thionville
Metz, 57085, France
NCT Number: NCT07385404
Heart failure (HF) represents a major public health challenge due to its increasing prevalence and significant impact on healthcare systems.
The burden of frequent readmissions leads to increased healthcare costs, deterioration in the quality of care, and reduced availability of hospital resources for new patients. It is therefore essential to optimize the management of patients with heart failure from their first visit to the emergency department in order to improve their prognosis and reduce the risk of rehospitalization.
In this context, this study aims to identify the key factors associated with early readmissions (< 30 days) and to propose strategies to improve patient management and follow-up after discharge from hospital.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
Metz, 57085, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months
Key factors determining the rehospitalization of patients with heart failure
Centre Hospitalier Régional Metz-Thionville
Other
Acronym: CARDIO-REA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06847438
Cardiovascular Diseases, Heart Diseases
Atlanta, Georgia, United States
View Trial DetailsNCT07721909
Cardiovascular Diseases, Heart Diseases
Muscat, Oman
View Trial DetailsNCT05820295
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial DetailsNCT05741658
Cardiovascular Diseases, Heart Diseases
Los Angeles, California, United States
View Trial Details